SciELO - Scientific Electronic Library Online

 
vol.67 issue2Miller-Dieker Syndrome: Two Cases Report author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista de la Facultad de Medicina (México)

On-line version ISSN 2448-4865Print version ISSN 0026-1742

Abstract

HERNANDEZ-GIRON, Carlos  and  CABRALES-ARREOLA, Jorge Luis. Coagulation Disorders: Factor V Leiden, Biological, Clinical, and Epidemiological Overview. Rev. Fac. Med. (Méx.) [online]. 2024, vol.67, n.2, pp.7-18.  Epub July 26, 2024. ISSN 2448-4865.  https://doi.org/10.22201/fm.24484865e.2024.67.2.02.

The coagulation system always keeps the blood in a fluid state and is therefore incessantly active throughout life. However, the moment an injury to the vascular system occurs, the coagulation system immediately rotates 180° and transforms the blood into a perfectly localized solid body, which we call a clot. This process, by which a clot forms, is known as hemostasis, which is one of the components of the coagulation system.

The importance of the Leiden mutation of factor V is based on the following: coagulation factor V is a protein that is synthesized in the liver and the gene that encodes it is located in region 23 of the long arm of chromosome 1, this factor circulates in peripheral blood inactively until it interacts with activated factor X forming a complex that converts factor II (prothrombin) into thrombin, which will have its action on fibrinogen turning it into fibrin. The regulation of activated factor V is given by the activity of activated protein C, when factor V has a mutation (named Leiden) that is caused by the exchange of an adenine for a guanine in the nucleotide 1691 of factor V (G1691A), which causes arginine to be replaced by a glutamine in the 506 residue of the factor V protein, the resulting protein is an abnormal factor V, which cannot be inactivated by activated protein C, so factor V remains activated and cannot prevent the clotting process from stopping. In our country (considering several conditions) it has been described in various publications of Mexican researchers that Leiden mutations of factor V and G20210A of prothrombin are not frequent, as they are in European countries.

Keywords : Thrombophilia; factor V Leiden; coagulation disorders; Mexico.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )